New Key Statistics Module, Z-Score and F-Score
NAS:IRWD Key Ratios
| Market Cap $ M | 716.31 |
| Enterprise Value $ M | 1,034.05 |
| P/E(ttm) | 5.63 |
| PE Ratio without NRI | 5.56 |
| Forward PE Ratio | 3.29 |
| Price/Book | -- |
| Price/Sales | 1.86 |
| Price/Free Cash Flow | 3.90 |
| Price/Owner Earnings | 4.28 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 389.00 |
| EPS (TTM) $ | 0.77 |
| Beneish M-Score | -3.1 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 202.80 |
| EV-to-EBIT | 4.31 |
| EV-to-EBITDA | 4.29 |
| PEG | -- |
| Shares Outstanding M | 165.24 |
| Net Margin (%) | 33.36 |
| Operating Margin % | 60.64 |
| Pre-tax Margin (%) | 53.27 |
| Quick Ratio | 6.06 |
| Current Ratio | 6.06 |
| ROA % (ttm) | 34.99 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | 47.97 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.95 |
IRWD Number of Guru Trades
IRWD Volume of Guru Trades
Gurus Latest Trades with NAS:IRWD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IRWD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ironwood Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:IRWD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers